Personalised breast cancer prevention

Know your risk. Protect your health.

Breast cancer can affect any woman—even without a family history. The AnteBC test provides a scientifically validated analysis of your personal breast cancer risk based on your genetic profile. Take charge of your health early—easily, safely, and conveniently from home.

Your benefits at a glance

• Genetic risk test via a simple cheek swab—can be done at home.

• Calculation of your individual polygenic breast cancer risk

• Personalized recommendations: When to start screening? How often?

• Specific actions to minimize risk

• CE-certified, GDPR-compliant, and clinically validated

• Optional: Video consultation – for personal support or to discuss results (one-time fee: only €150 extra)

Who is this test suitable for?

• Recommended for all women age 30 and up

• Especially helpful for women under 50 to detect increased risk early

• Ideal for health-conscious women – with or without a family history

• Accessible everywhere through at-home testing and digital prevention recommendations

What is tested?

The test determines your breast cancer risk using a polygenic risk score (PRS) that combines the effects of 2,803 common genetic variants.
Unlike rare mutations such as BRCA1/2, polygenic risk is based on the interaction of many genetic variants—so an increased risk is possible even without a family history.
Your risk assessment also takes into account age, ancestry, and sex—enabling a personalized prevention plan with clinical recommendations.

Result: Genetic counseling must be provided verbally, but the patient may waive the verbal counseling if the information is made available in writing. The waiver of verbal counseling or consent to written counseling must be documented.

What does this mean for you specifically?

• Your personal risk score compared to the average female population

• Assessment of your likelihood of developing breast cancer in the next 10 years.

• Specific medical recommendations for prevention and early detection

• A medical report for you and your treating physician

Important information:

• The test is not a diagnostic tool

• A high risk doesn't necessarily mean illness—a low risk doesn't rule it out

• Rare high-risk mutations (e.g., BRCA1, BRCA2) are not included.

• Based on UK Biobank data, CE-certified as an IVD in the EU and UK.

• Scientific models can evolve with new findings

Legal & scientific information

In accordance with the German Genetic Diagnostics Act (GenDG), you will receive all legally required information in writing before and after the test.

• Before the test: Written information about the purpose, procedure, and possible results
• After the test: Digital report and personalized prevention plan
• Optional: Personal consultation via video for just €150 – bookable at the following link